Company profilePharmaceutical#953 of 1,318 in Pakistan✓ No DRAP alerts

ASTER LIFE SCIENCES DSL: 053520065013801D

Pharmaceutical company · 5 brands · 9 molecules

Ranked #7 of 8 companies in Other Bacterial And Viral Vaccines

5 registered products 9 pharmaceutical brands 9 distinct molecules 0 DRAP alerts

Company overview

5
registered products
9
pharmaceutical brands
9
distinct molecules
1
therapeutic classes
0
DRAP alerts

ASTER LIFE SCIENCES DSL: 053520065013801D is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 5 product registrations across 9 distinct molecules. Its portfolio is concentrated in Other Bacterial And Viral Vaccines. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ASTER

8 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

8
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20268

Top molecules by brand count

Octreotide ...... 0.1 Mg1 brand
Paclitaxel ...... 100 Mg1 brand
Diphtheria Toxoid ...... 15 Lf1 brand
Recombinant Human Erythropoietin ...... 2000 Iu1 brand
Recombinant Human Erythropoietin ...... 10000 Iu1 brand
Recombinant Human Erythropoietin ...... 4000 Iu1 brand
Cyclosporin ...... 100 Mg1 brand
Cyclosporin ...... 50 Mg1 brand
Cyclosporin ...... 25 Mg1 brand

Therapeutic classes

Other Bacterial And Viral Vaccines · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official10 products · Rs 2,240.47 – Rs 41,334.31
Median across source: Rs 13,794.82

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

RG PHARMA3 shared molecules
ALLMED LABORATORIES3 shared molecules
BF BIOSCIENCE LTD2 shared molecules
Medipak (Pvt) Ltd2 shared molecules
SCOTMANN PHARMACEUTICALS2 shared molecules
ASTER LIFE SCIENCES1 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

AJ Mirza Pharma Pvt Ltd DSL: 235 holds 18 molecules not in this portfolio
AtorvastatinBovine Lipid Extract SurfactantCapecitabineEntecavirErlotinibFlutamide
RG PHARMA holds 12 molecules not in this portfolio
CalciumCilnidipineDoxylamineEpoetin BetaFerric Carboxymaltose ComplexFolic Acid
ALLMED LABORATORIES holds 62 molecules not in this portfolio
AlbuterolArtemetherArtesunateAscorbic AcidAzithromycinCalcium

Get the full profile for ASTER

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.